Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a new revision tag: Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor page revision/update in the site's documentation.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page shows a new Revision: v3.6.2, replacing v3.6.0. This indicates a backend or documentation version update without altering the study details.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now shows that recruitment has ended with 'No longer looking for participants', signaling termination. It also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label along with a revision note to v3.6.0 (from v3.5.5).SummaryDifference0.6%

- Check41 days agoChange DetectedRevision: v3.5.5 is now displayed in the Study Documents section, replacing Revision: v3.5.4. This indicates a newer version of the documents or metadata on the page, and does not modify trial data or eligibility.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing v3.5.3, indicating a minor update to the site's versioning. No study content or data appear to be affected.SummaryDifference0.1%

- Check83 days agoChange DetectedUpdates the site’s displayed revision/version identifier from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.